COVID-19 VACCINE TRIALS IN AFRICA
Oct 01, 2020
1 minute
Novavax, a US drug developer of next-generation vaccines for serious infectious diseases, began screening participants to enroll in the mid-stage study of an experimental Covid-19
You’re reading a preview, subscribe to read more.
Start your free 30 days